-
Nov 19, 2024 | 
pharmafocusasia.com | Feng Yuan |Yingshuai Wang |Lei Yuan |Yangchun Hu |Hongwei Cheng
Feng Yuan, Yingshuai Wang, Lei Yuan, Lei Ye, Yangchun Hu, Hongwei Cheng, Yan Li.AbstractGlioma is a highly heterogeneous and poorly immunogenic malignant tumor, with limited efficacy of immunotherapy. The characteristics of the immunosuppressive tumor microenvironment (TME) are one of the important factors hindering the effectiveness of immunotherapy.
-
Aug 30, 2024 | 
mdpi.com | Hongwei Cheng |Andrew James |Mark B. Cannell |Jules C. Hancox
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Aug 4, 2024 | 
onlinelibrary.wiley.com | Hongwei Cheng |Northwest Xi'an |Xiangbo Li |Jiabao Du
1 INTRODUCTION The skin constitutes approximately 15% of the total body weight in humans and serves as a vital interface with the external environment, functioning as a primary defense system.1 Its pivotal role encompasses not only the prevention of entry for harmful agents such as ultraviolet radiation, microbial pathogens, and antigens but also the regulation of body homeostasis. The skin comprises the epidermis, the dermis, and subcutaneous tissues in the structure.
-
May 9, 2024 | 
onlinelibrary.wiley.com | Liao Guan |Wenwen Wang |Xuefei Ji |Hongwei Cheng
Introduction Glioblastoma (GBM) is a frequent and invasive primary central nervous system (CNS) tumor in adults.1 According to the World Health Organization tumor classification, GBM is one of the highest graded gliomas featuring necrosis or microvascular hyperplasia.2 Multimodality treatments against GBM usually incorporate neurosurgery with subsequent radio- and/or chemo-therapies.
-
Nov 3, 2023 | 
frontiersin.org | Qun Zhang |Hongwei Cheng |Nektarios Koufopoulos
IntroductionGastric cancer is a frequently occurring malignant tumor of the digestive tract that is the fourth most common cancer-related cause of death globally (1). Adenocarcinoma is the most common pathological type of gastric cancer, characterized mainly by distant metastases. Gastric cancer often metastasizes to the local lymph nodes, liver, lung, bone and peritoneum. Ovarian metastasis is sometimes observed in women. However, brain metastasis occurs less often, with a 6.5% incidence rate (2).
-
Nov 1, 2023 | 
frontiersin.org | Dexiang Gao |Hongwei Cheng |Zhang Yu
1 IntroductionHepatocellular carcinoma (HCC) is the sixth most frequently occurring cancer worldwide and the third most common cause of cancer mortality (1). HCC is highly associated with chronic viral hepatitis (2, 3), alcohol (4), smoke (5), iron (6), and metabolic dysfunction (7, 8). To date, hepatitis B virus (HBV) and hepatitis C virus (HCV) have been reported as commonest risk factors for HCC. Almost half of HCCs are associated with HBV infection, and this figure is even higher in Asian.
-
Sep 25, 2023 | 
frontiersin.org | Guanghua Rong |Hongwei Cheng |Zhi Yuan Mao |Zhi-De Hu
Highlights• All systemic combinations (chemotherapy plus chemotherapy, targeted therapy plus ICI therapy, targeted therapy plus chemotherapy, and targeted plus targeted therapies) significantly improve the objective response rate in patients with aHCC. • The targeted therapy plus ICI therapy showed better therapeutic efficiency in overall survival, progression-free survival, and objective response rate, compared to the monotherapy.
-
Sep 15, 2023 | 
frontiersin.org | Andreas Behren |Raheleh Roudi |Hongwei Cheng
1 IntroductionGastric cancer (GC) is the fifth most common cancer and the fourth leading cause of cancer-related mortality in the world (1). Although fluoropyrimidines and platinum-based chemotherapy as first-line therapy and taxanes plus ramucirumab as second-line therapy are standard treatment for GC, prognosis remains poor and median survival is approximately one year (2–5).
-
Aug 29, 2023 | 
mdpi.com | Banglong Pan |Hanming Yu |Hongwei Cheng |Shuhua Du
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticleby 1,*, 1, 1, 2, 1, 1, 1 and 1 1The School of Environmental and Energy Engineering, Anhui Jianzhu University, Heifei 230000, China2Institute of Geological Experiments of Anhui Province, Heifei 230000, China*Author to whom correspondence should be addressed.
-
Aug 27, 2023 | 
onlinelibrary.wiley.com | Wei Nie |Yongfu Tang |Hongwei Cheng |Feng Tian
Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description smll202306351-sup-0001-SuppMat.pdf1.8 MB Supporting Information References 1, , , , , , Adv. Energy Mater. 2018, 8, 1702028. 2, , , , , , Mater. Today 2020, 43, 132. 3, , , , , , , , Small 2022, 18, 2204613. 4, , Adv. Energy Mater. 2018, 8, 1802057. 5, , , , Energy Environ. Sci. 2018, 11, 243. 6, , , , , , , eTransportation 2019, 1,100005. 7, , , , , , Adv.
